Cartalax
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the Khavinson group of short peptide bioregulators, associated with cartilage tissue. It has been studied in cell-culture models for effects on chondrocyte and fibroblast function and gene expression.
For in-vitro laboratory research only. Not for human or veterinary use.
Reference data
Lab reports
Storage & handling
Store lyophilized material at -20°C, protected from light and moisture.
Handle in a laboratory setting using appropriate personal protective equipment.
Questions about Cartalax
What is Cartalax?
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) from the Khavinson group of short peptide bioregulators, associated with cartilage tissue. It has been studied in cell-culture models for effects on chondrocyte and fibroblast function and gene expression.
What is the molecular formula and weight of Cartalax?
Molecular Formula: C12H19N3O8. Molecular Weight: 333.30 g/mol.
How is Cartalax tested?
Every lot of Cartalax is analysed by an independent, third-party laboratory using HPLC for identity and purity. The Certificate of Analysis for each lot — lot number, test date and result — is published and listed on this page.
How should Cartalax be stored?
Store lyophilized material at -20°C, protected from light and moisture.
Is Cartalax for human use?
No. Cartalax is sold strictly for in-vitro laboratory research by qualified researchers aged 21 and over. It is not for human or veterinary use and is not a drug, food, supplement or cosmetic.
